SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: MissLil who wrote (8082)5/15/1998 11:16:00 AM
From: Frostman  Read Replies (1) | Respond to of 23519
 
Agree on the PR observation, been my main complaint for over a year.
If a new issue, highly traded stock doesn't have someone on board who can pick up the phone and talk to TV anchors, magazine/print editors, and radio hosts by their first name, something is wrong. Vivus has missed countless opportunities because nobody knew who they were. Now that they have an angle and high visibility, they are, as usual, doing little with the momentum and the opportunity. The CEO should have several publishable releases on his desk every morning and see to it that the best hit the the wire. These are big boy/girl rules. See how they play. Vivus watches from the sidelines frequently, and waits for what? All in my opinion.

Frostman



To: MissLil who wrote (8082)5/15/1998 5:59:00 PM
From: RealMuLan  Respond to of 23519
 
I read from WSJ that Vivus submitted an audio ad, and the narrative was by a woman's voice. The FDA asked the company to redo it with a man's voice. They said woman's voice will mislead the potential customers, things like that. Funny.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News